NASDAQ:RIGL

Rigel Pharmaceuticals Stock Predictions

Healthcare > Biotechnology

Buy RIGL

*Your capital is at risk

$30.30

+0.280 (+0.93%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

RIGL Prediction Chart

RIGL Predictions History

Latest community submissions for RIGL.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
mrcriter	Aug 19, 2016	$3.09 -89.34%	$2.90	X	93.40%	0
shawn.fegely	Jul 11, 2016	$2.58 -88.33%	$2.21	X	83.30%	0
shawn.fegely	Jul 7, 2016	$2.30 -89.59%	$2.21	X	95.90%	0
shawn.fegely	Jul 6, 2016	$2.30 -89.91%	$2.28	X	99.10%	2
shawn.fegely	Jul 5, 2016	$2.30 -89.78%	$2.25	X	97.80%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for RIGL with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT RIGEL PHARMACEUTICALS

Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is in phase III clinical trial for the treatment of warm autoimmune hemolytic anemia; phase III clinical t...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by